IBDEI3GT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,58282,1,4,0)
 ;;=4^E08.319
 ;;^UTILITY(U,$J,358.3,58282,2)
 ;;=^5002511
 ;;^UTILITY(U,$J,358.3,58283,0)
 ;;=E08.321^^272^2905^35
 ;;^UTILITY(U,$J,358.3,58283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58283,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58283,1,4,0)
 ;;=4^E08.321
 ;;^UTILITY(U,$J,358.3,58283,2)
 ;;=^5002512
 ;;^UTILITY(U,$J,358.3,58284,0)
 ;;=E08.329^^272^2905^36
 ;;^UTILITY(U,$J,358.3,58284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58284,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58284,1,4,0)
 ;;=4^E08.329
 ;;^UTILITY(U,$J,358.3,58284,2)
 ;;=^5002513
 ;;^UTILITY(U,$J,358.3,58285,0)
 ;;=E08.331^^272^2905^37
 ;;^UTILITY(U,$J,358.3,58285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58285,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58285,1,4,0)
 ;;=4^E08.331
 ;;^UTILITY(U,$J,358.3,58285,2)
 ;;=^5002514
 ;;^UTILITY(U,$J,358.3,58286,0)
 ;;=E08.339^^272^2905^38
 ;;^UTILITY(U,$J,358.3,58286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58286,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58286,1,4,0)
 ;;=4^E08.339
 ;;^UTILITY(U,$J,358.3,58286,2)
 ;;=^5002515
 ;;^UTILITY(U,$J,358.3,58287,0)
 ;;=E08.341^^272^2905^39
 ;;^UTILITY(U,$J,358.3,58287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58287,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58287,1,4,0)
 ;;=4^E08.341
 ;;^UTILITY(U,$J,358.3,58287,2)
 ;;=^5002516
 ;;^UTILITY(U,$J,358.3,58288,0)
 ;;=E08.349^^272^2905^40
 ;;^UTILITY(U,$J,358.3,58288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58288,1,3,0)
 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58288,1,4,0)
 ;;=4^E08.349
 ;;^UTILITY(U,$J,358.3,58288,2)
 ;;=^5002517
 ;;^UTILITY(U,$J,358.3,58289,0)
 ;;=E09.311^^272^2905^31
 ;;^UTILITY(U,$J,358.3,58289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58289,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58289,1,4,0)
 ;;=4^E09.311
 ;;^UTILITY(U,$J,358.3,58289,2)
 ;;=^5002552
 ;;^UTILITY(U,$J,358.3,58290,0)
 ;;=E09.319^^272^2905^32
 ;;^UTILITY(U,$J,358.3,58290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58290,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58290,1,4,0)
 ;;=4^E09.319
 ;;^UTILITY(U,$J,358.3,58290,2)
 ;;=^5002553
 ;;^UTILITY(U,$J,358.3,58291,0)
 ;;=E09.321^^272^2905^27
 ;;^UTILITY(U,$J,358.3,58291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58291,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58291,1,4,0)
 ;;=4^E09.321
 ;;^UTILITY(U,$J,358.3,58291,2)
 ;;=^5002554
 ;;^UTILITY(U,$J,358.3,58292,0)
 ;;=E09.329^^272^2905^28
 ;;^UTILITY(U,$J,358.3,58292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58292,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,58292,1,4,0)
 ;;=4^E09.329
 ;;^UTILITY(U,$J,358.3,58292,2)
 ;;=^5002555
 ;;^UTILITY(U,$J,358.3,58293,0)
 ;;=E09.351^^272^2905^29
 ;;^UTILITY(U,$J,358.3,58293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,58293,1,3,0)
 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,58293,1,4,0)
 ;;=4^E09.351
 ;;^UTILITY(U,$J,358.3,58293,2)
 ;;=^5002560
